Sangamo Therapeutics, Inc. Financial Ratios — SGMOQ Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-52.56	-30.7	-28.53	-16.09	-20.4	-43.61	-33.67	-24.65	-23.82	-26	-40.82	-57.37	-136.47	-185.39	- -
Return on Assets (%)	-47.56	-26.21	-23.84	-13.76	-17.68	-38.2	-24.55	-15.58	-15.5	-15.35	-21.47	-29.94	-70.85	-73.38	-152.35
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-340.88	-99.46	-108.3	-57.19	-116.01	-369.09	-150.03	-88.56	-93.31	-98.3	-149.68	-162.37	-54.93	-154.13	-253.85
Operating Margin (%)	-347.14	-102.51	-110.66	-58.38	-118.51	-374.23	-154.13	-91.35	-102.69	-109.61	-165.61	-180.85	-67.52	-170.33	-273.07
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-346.45	-102.81	-110.32	-57.59	-117.42	-369.65	-149.23	-81.57	-93.16	-102.19	-160.79	-172.37	-149.18	-169.74	-312.25
Profit Margin (%)	-346.45	-102.81	-110.32	-57.59	-102.94	-369.58	-149.23	-80.91	-92.93	-102.37	-161.05	-172.76	-146.3	-169.45	-310.81
Net Income to Common Margin (%)	-346.45	-102.81	-110.32	-57.59	-102.94	-369.58	-149.23	-80.91	-92.93	-102.37	-161.05	-172.76	-146.3	-169.45	-310.81
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-52.56	-30.7	-28.53	-16.09	-20.4	-43.61	-33.67	-24.65	-23.82	-26	-40.82	-57.37	-136.47	-185.39	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	4	25	28	44	42	48	43	38	31	27
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	3	4	4	4	5	4	2
LT Debt	- -	- -	- -	- -	- -	4	25	28	41	38	44	39	34	26	25
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.06	-0.45	-0.37	-0.46	-0.36	-0.29	-0.24	-0.39	-0.34	-0.27
Net Debt/EBITDA	0.48	1.01	0.39	0.23	1.51	0.31	0.91	1.88	0.84	1.13	1.08	0.56	0.47	0.47	0.21
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.05	-0.44	-0.36	-0.42	-0.32	-0.26	-0.21	-0.32	-0.31	-0.25
Net Debt/EBIT	0.47	0.98	0.38	0.23	1.48	0.3	0.88	1.82	0.76	1.01	0.98	0.5	0.38	0.43	0.19
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	91.75	78.63	86.42	84.96	88.59	86.26	65.53	62.08	67.85	53.09	51.99	52.44	50.14	22.4	-23.88
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	2.9	13.17	7.54	9.52	7.72	11.74	13.22	40.43	115.3	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	2.82	11.63	7.01	8.63	7.12	10.4	11.53	27.7	49.22	200.31
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.46	4.09	6.1	6.93	20.27	25.83	42
Total Debt/Equity (%)	- -	- -	- -	- -	- -	2.9	13.17	7.54	10.26	8.46	12.81	14.61	45.97	134.24	-187.8
Total Debt/Capital (%)	- -	- -	- -	- -	- -	2.82	11.63	7.01	9.31	7.8	11.36	12.75	31.49	57.31	213.9
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.97	4.48	6.66	7.66	23.05	30.07	44.85
Net Debt to Equity	-20.92	-33.41	-8.37	-2.92	-36.11	-16.2	-26.52	-38.23	-18.59	-26.4	-47.66	-34.05	-54.54	-184.09	146.82
Net Debt/Capital (%)	-26.46	-50.16	-9.13	-3.01	-56.51	-18.68	-30.6	-55.17	-20.27	-32.18	-73.14	-42.27	-59.65	-367.12	248.76
EBITDA	-35	-22	-26	-26	-46	-72	-55	-75	-96	-116	-166	-181	-97	-89	-100
EBITDA-CapEx	-36	-22	-27	-26	-46	-72	-59	-118	-116	-131	-189	-201	-118	-89	-101
Operating Income (Loss)	-36	-22	-27	-27	-47	-73	-56	-77	-105	-130	-183	-201	-119	-98	-108

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	11.68	7.23	9.16	8.57	10.4	10.72	5.42	5.1	5.19	4.47	2.94	2.49	1.7	0.92	0.49
Current Ratio	11.9	7.78	9.6	9.14	10.58	11.25	5.54	5.23	5.8	4.6	3.12	2.69	1.98	1.13	0.84
Quick Ratio	11.85	7.72	9.51	9.09	10.54	11.12	5.5	5.16	5.73	4.51	2.99	2.53	1.78	1.02	0.74
CFO/Avg Current Liab	-3.62	-1.01	-2.06	-0.37	-1.65	-3.95	0.38	0.59	-1.95	1.59	-1.72	-1.87	-2.82	-1.44	-2.2
Common Equity/Total Assets	91.75	78.63	86.42	84.96	88.59	86.26	65.53	62.08	67.85	53.09	51.99	52.44	50.14	22.4	-23.88
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	2.9	13.17	7.54	9.52	7.72	11.74	13.22	40.43	115.3	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	2.82	11.63	7.01	8.63	7.12	10.4	11.53	27.7	49.22	200.31
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.46	4.09	6.1	6.93	20.27	25.83	42
Total Debt/Equity (%)	- -	- -	- -	- -	- -	2.9	13.17	7.54	10.26	8.46	12.81	14.61	45.97	134.24	-187.8
Total Debt/Capital (%)	- -	- -	- -	- -	- -	2.82	11.63	7.01	9.31	7.8	11.36	12.75	31.49	57.31	213.9
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	2.5	8.63	4.69	6.97	4.48	6.66	7.66	23.05	30.07	44.85
CFO/Total Liabilities	-359.45	-45.82	-101.85	-15.51	-135.99	-303.66	11.31	16.38	-70.52	38.5	-67.3	-83.58	-272.76	-85.13	-131.34
CFO/CapEx	-44.96	-11.18	-45.1	- -	- -	-90	2.98	0.85	-6.98	11.55	-10.02	-11.09	-10.63	-251.46	-953.02
Altman's Z-Score	8.21	6.42	24.34	15.99	13.68	1.67	6.42	2.03	1.45	2.09	-0.5	-2.9	-12.18	-21.63	-42.37

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	16.06	8.58	6.63	6.78	6.14	5.18	8.8	21.07	4.93	5.61	19.7	22.97	76.61	79.78	88.19
Days Sales Outstanding	22.73	42.54	55.08	53.8	59.49	70.53	41.5	17.32	74.09	65.06	18.53	15.89	4.76	4.58	4.14
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	149	319	865	1,050	642	216	1,404	1,173	971	2,218	1,094	524	96	217	147
- Cash & Cash Equivalents	17	22	10	6	69	22	50	140	80	131	179	100	45	42	21
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	1	- -	-1	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	4	25	28	44	42	48	43	38	31	27
Enterprise Value	65	255	772	871	433	78	1,185	801	653	1,617	766	289	53	206	153
Total Capital	80	65	122	207	192	140	213	395	477	539	423	338	121	53	13
Total Debt/Capital (%)	- -	- -	- -	- -	- -	2.82	11.63	7.01	9.31	7.8	11.36	12.75	31.49	57.31	213.9
Total Debt / EV	- -	- -	- -	- -	- -	0.05	0.02	0.03	0.07	0.03	0.06	0.15	0.71	0.15	0.17
EV/Sales	6.31	11.79	31.98	19	10.96	4	32.41	9.49	6.37	13.68	6.92	2.6	0.3	3.56	3.87
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	106.02	21.93	- -	9.52	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	79.39	10.07	- -	8.76	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	-17	-22	-10	-6	-69	-18	-25	-112	-36	-90	-131	-57	-7	-11	6
EV per Share	1.24	4.81	12.4	12.62	6.16	1.09	13.85	7.84	5.63	11.39	5.25	1.73	0.3	0.97	0.44
TTM Sales	10	22	24	46	40	19	37	84	102	118	111	111	176	58	40
TTM EBITDA	-35	-22	-26	-26	-46	-72	-55	-75	-96	-116	-166	-181	-97	-89	-100
TTM Operating Income	-36	-22	-27	-27	-47	-73	-56	-77	-105	-130	-183	-201	-119	-98	-108
TTM Cash Flow to Firm	-26	-8	-19	-6	-34	-66	11	37	-144	170	-233	-224	-225	-67	-97
TTM Free Cash Flow to Firm	-25	-7	-19	-6	-34	-65	15	80	-124	185	-210	-203	-204	-67	-97

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	65	255	772	871	433	78	1,185	801	653	1,617	766	289	53	206	153
Low Price	2.36	2.81	6.03	9.39	5.3	2.65	3	9	6.26	4.81	7.05	2.72	0.29	0.3	0.38
EV/Sales	6.31	11.79	31.98	19	10.96	4	32.41	9.49	6.37	13.68	6.92	2.6	0.3	3.56	3.87
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	1.86	4.91	7.1	5.08	3.34	1.59	7.47	3.2	2.24	4.45	2.92	1.78	1.16	9.53	-10.32
Price/Book Value Average	3.72	4.12	5.01	4.9	4.03	2.74	4.15	4.56	2.77	2.8	4.2	2.73	3.08	8.98	-16.59
Price/Book Value High	6	5.56	7.47	8.25	7.04	4.8	8.38	7.67	3.73	5.54	6.82	4.52	8.08	29.72	-37.11
Price/Book Value Low	1.55	2.3	3.08	3.14	1.94	1.38	1.37	2.51	1.68	1.37	2.74	1.54	0.62	2.8	-9.34
Price/Tangible Book Value	1.86	4.91	7.31	5.17	3.37	1.61	7.53	4.31	2.85	5.58	3.88	2.53	1.16	9.53	-10.32
Price/Tangible Book Value Average	3.72	4.12	5.15	4.98	4.06	2.78	4.19	6.14	3.52	3.51	5.6	3.89	3.08	8.98	-16.59
Price/Tangible Book Value High	6	5.56	7.68	8.39	7.1	4.85	8.45	10.32	4.74	6.95	9.07	6.45	8.08	29.72	-37.11
Price/Tangible Book Value Low	1.55	2.3	3.17	3.19	1.95	1.4	1.38	3.38	2.13	1.72	3.65	2.2	0.62	2.8	-9.34
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	27.23	11.35	24.83	21.95	17.85	18.34	20.64	18.47	11.33	11.05	13.07	6.71	1.41	3.34	6.13
EV/Sales High	44.98	15.66	37.23	37.04	32.5	32.77	42.39	31.95	15.4	22.59	21.93	11.46	3.76	11.51	13.54
EV/Sales Low	10.39	5.88	15.13	14.01	7.67	8.75	6.34	9.56	6.74	5.02	8.11	3.56	0.25	0.91	3.52
EV/EBITDA Average	-7.99	-11.41	-22.93	-38.38	-15.39	-4.97	-13.76	-20.86	-12.14	-11.24	-8.73	-4.13	-2.56	-2.17	-2.42
EV/EBITDA High	-13.19	-15.75	-34.38	-64.77	-28.01	-8.88	-28.25	-36.08	-16.5	-22.98	-14.65	-7.06	-6.85	-7.47	-5.33
EV/EBITDA Low	-3.05	-5.92	-13.97	-24.49	-6.61	-2.37	-4.22	-10.8	-7.22	-5.11	-5.42	-2.19	-0.46	-0.59	-1.39
EV/EBIT Average	-7.85	-11.07	-22.44	-37.59	-15.06	-4.9	-13.39	-20.22	-11.03	-10.08	-7.89	-3.71	-2.09	-1.96	-2.25
EV/EBIT High	-12.96	-15.28	-33.65	-63.44	-27.42	-8.76	-27.5	-34.97	-15	-20.61	-13.24	-6.34	-5.57	-6.76	-4.96
EV/EBIT Low	-2.99	-5.74	-13.67	-23.99	-6.48	-2.34	-4.11	-10.47	-6.56	-4.58	-4.9	-1.97	-0.37	-0.53	-1.29
Last Price	2.84	6.01	13.89	15.21	9.13	3.05	16.4	11.48	8.37	15.61	7.5	3.14	0.54	1.02	0.42
High Price	9.15	6.8	14.6	24.69	19.25	9.22	18.4	27.5	13.91	19.43	17.53	7.99	3.76	3.18	1.51
Enterprise Value Average	281	246	599	1,007	706	356	755	1,560	1,160	1,306	1,446	747	248	193	243
Enterprise Value High	464	339	899	1,699	1,285	635	1,550	2,698	1,577	2,670	2,427	1,275	663	665	535
Enterprise Value Low	107	127	365	642	303	170	232	808	690	593	898	396	45	52	139

Shares Outstanding	53	53	62	69	70	71	86	102	116	142	146	167	178	213	351
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	1.6	1.2	1.49	2.59	2.97	2.01	2.84	3.92	3.13	4.52	2.58	1.66	0.45	0.2	0.06
Book Value per Share	1.52	1.22	1.96	2.99	2.74	1.92	2.2	3.59	3.73	3.51	2.57	1.77	0.47	0.11	-0.04
Tangible Book Value per Share	1.52	1.22	1.9	2.94	2.71	1.9	2.18	2.66	2.93	2.8	1.93	1.24	0.47	0.11	-0.04

Sangamo Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)